Zidovudine

Product NDC: 0527-1905
11-digit product format: 005271905
Labeler code: 0527
Product ID: 0527-1905_97e8316d-3b9f-0999-e053-2995a90a06bb
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Zidovudine
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Lannett Company, Inc.
Application: ANDA202058
Marketing category: ANDA
Marketing start: 2014-03-25
Marketing end: 0000-00-00
Substance: ZIDOVUDINE
Active strength: 300 mg/1
Pharmacologic classes: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0527-1905-06	EA - Each	0527-1905	0811da47-acbf-4919-9846-fa98c71e637f	1	2014-06-03

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4B9XT59T7S	ZIDOVUDINE	30516-87-1	ZIDOVUDINE

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0527-1905-06	00527190506	60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-1905-06)	2014-03-25	0000-00-00	No	No	Current